Organisational changes at Covidien
This article was originally published in Scrip
Executive Summary
Covidien has appointed Bryan Hanson group president with responsibility for the surgical devices and energy-based devices businesses, Peter Wehrly group president with responsibility for the respiratory and monitoring solutions and vascular therapies businesses and regional responsibility for Japan, and Michael Sgrignari senior vice-president of quality and operations. They have all been appointed from within Covidien, and will report to José Almeida, president of medical devices and CEO-elect. James Muse, senior vice-president of global supply chain and Scott Flora, president of surgical devices, have left the company.